신경 자극 기기 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global neurostimulation devices market size is expected to reach USD 16.75 Billion in 2034 from USD 6.84 Billion in 2025, growing at a CAGR of 10.46 during 2026-2034.The global neurostimulation devices market is experiencing strong growth due to increasing demand for advanced treatments for neurological disorders. Neurostimulation devices use electrical impulses to stimulate specific areas of the nervous system in order to manage conditions such as chronic pain, Parkinson's disease, epilepsy, and depression. Healthcare providers are increasingly adopting these devices as they offer effective treatment options for patients who do not respond well to conventional medications.

Several factors are driving the expansion of this market. The rising prevalence of neurological disorders and chronic pain conditions is increasing the demand for innovative treatment solutions. In addition, growing awareness about minimally invasive therapies is encouraging patients and healthcare professionals to consider neurostimulation devices. Continuous technological advancements, including improved battery life, wireless programming, and smaller implantable devices, are also supporting market growth.

The future of the neurostimulation devices market appears highly promising as research in neuroscience and medical technology continues to advance. Increasing investments in healthcare innovation and expanding access to specialized neurological treatments will likely support wider adoption. Furthermore, the development of next-generation devices capable of providing more precise stimulation is expected to enhance treatment effectiveness and create new opportunities in the market.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Deep brain stimulator
• Gastric electric stimulator
• Spinal cord stimulator
• Sacral nerve stimulator
• Vagus nerve stimulator
• Transcutaneous electrical nerve stimulation (TENS)
• Other products

By Application

• Pain management
• Epilepsy
• Essential tremor
• Urinary and fecal incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's disease
• Other applications

COMPANIES PROFILED

• Abbott Laboratories, Aleva Neurotherapeutics S.A., BioControl Medical, Boston Scientific Corporation, ElectroCore Inc., Endostim, Helbling Holding AG, Innovative Health Solutions Inc., Laborie Inc., LivaNova PLC, Medtronic plc, MicroTransponder, Neuronetics Inc., Parasym Ltd., RS Medical

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Deep brain stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gastric electric stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Spinal cord stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sacral nerve stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Vagus nerve stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Transcutaneous electrical nerve stimulation (TENS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Other products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Essential tremor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Urinary and fecal incontinence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Depression Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Dystonia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Gastroparesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Parkinson's disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEUROSTIMULATION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 Aleva Neurotherapeutics S.A
  • 8.2.3 BioControl Medical
  • 8.2.4 Boston Scientific Corporation
  • 8.2.5 ElectroCore Inc
  • 8.2.6 Endostim
  • 8.2.7 Helbling Holding AG
  • 8.2.8 Innovative Health Solutions Inc
  • 8.2.9 Laborie Inc
  • 8.2.10 LivaNova PLC
  • 8.2.11 Medtronic Plc
  • 8.2.12 MicroTransponder
  • 8.2.13 Neuronetics Inc
  • 8.2.14 Parasym Ltd
  • 8.2.15 RS Medical